Yili Chuannig Biotechnology Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
36.54 | 69.4 | -47.35% | 0 | 0% |
| P/S |
|
4.3 | 6.51 | -33.92% |
|
|
| P/BV |
|
3.06 | 3.96 | -22.65% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
30.12 | 11.85 | 154.21% |
|
|
| Ev/S |
|
5.24 | 5.98 | -12.27% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.025 | 0.0396 | -36.86% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
32.27 | 20.39 | 58.29% | 32.27 | 0% |
| ROE |
|
8.71 | 11.95 | -27.09% |
|
|
| ROA |
|
4.94 | 5.4 | -8.55% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
11.89 | 16.23 | -26.75% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
6/10
|
2.25 | 14.63 | -84.62% | 2.25 | 0% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
6.11 | 3.6 | 69.62% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.6/10
|
1.04 | 1.83 | -43.26% | 1.02 | +1.69% |
| Number of years of dividend growth |
|
1 | 1.44 | -30.43% | ||
| DSI |
|
0.75 | 0.9113 | -17.7% |
|
|
| Average dividend growth |
|
0 | 10.4 | -100% |
|
|
| Average percentage for 5 years |
|
1.02 | 1.14 | -10.45% |
|
|
| Average percentage for payments |
|
0 | 44.8 | -100% |
|
|
| Difference from average difference in sector |
|
-0.793 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
0 | 61.43 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
0 | 158.62 | -100% | ||
| Growth impulse Net Income in 5 years |
|
0 | 66.93 | -100% | ||
| Growth impulse FCF in 5 years |
|
0 | 248.41 | -100% | ||
| Growth impulse EPS in 5 years |
|
1088.48 | 73.29 | 1385.17% |
IP Score
4.87/10
